These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 30549987)

  • 1. Long Non-Coding RNA TUG1 as a Potential Novel Biomarker for Predicting the Clinical Outcome of Cancer Patients: a Meta-Analysis.
    Li B; Shen S; Zhang W; Qi T; Hu Q; Cheng Y
    Clin Lab; 2018 Oct; 64(11):. PubMed ID: 30549987
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic role of lncRNA TUG1 for cancer outcome: Evidence from 840 cancer patients.
    Liu J; Lin J; Li Y; Zhang Y; Chen X
    Oncotarget; 2017 Jul; 8(30):50051-50060. PubMed ID: 28548946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA UCA1 as a novel biomarker of lymph node metastasis and prognosis in human cancer: a meta-analysis.
    Liu C; Jin J; Shi J; Wang L; Gao Z; Guo T; He Y
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30918102
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
    Liu X; Huang G; Zhang J; Zhang L; Liang Z
    PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA Taurine Upregulated Gene 1 as a Potential Biomarker in the Clinicopathology and Prognosis of Multiple Malignant Tumors: A Meta-Analysis.
    Huang Q; Wu J; Wang H; Li N; Yang Z; Zhang M
    Dis Markers; 2021; 2021():8818363. PubMed ID: 33747256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA TUG1 as a potential prognostic biomarker in human cancers: a meta-analysis.
    Ma PJ; Guan QK; Meng L; Qin N; Zhao J; Jin BZ
    Oncotarget; 2017 Sep; 8(37):62454-62462. PubMed ID: 28977959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA taurine-up regulated gene 1 for the prognosis of osteosarcoma: A protocol for meta-analysis and bioinformatics analysis.
    Ren Z; Li C; Gan Y; Liu X; Liang F
    Medicine (Baltimore); 2021 Jun; 100(24):e26182. PubMed ID: 34128849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-codingRNA (lncRNA) TUG1 and the prognosis of cancer: a meta-analysis.
    Yu XH; Guo W; Zhang J; Ma C; Chu AJ; Wen BL; Zhang X; Yan XY; Wu CM; Wang DM; Qu YL
    Cell Mol Biol (Noisy-le-grand); 2017 Mar; 63(3):36-39. PubMed ID: 28466821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of lncRNA FEZF1 antisense RNA 1 over-expression in oncologic outcomes of patients with solid tumors.
    Zhang Y; Yang QX; Peng TT; Wang LJ; Xiao GL; Tang SB
    Medicine (Baltimore); 2019 Jun; 98(24):e15982. PubMed ID: 31192939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA NEAT1 overexpression is associated with poor prognosis in cancer patients: a systematic review and meta-analysis.
    Yang C; Li Z; Li Y; Xu R; Wang Y; Tian Y; Chen W
    Oncotarget; 2017 Jan; 8(2):2672-2680. PubMed ID: 27926523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of prognostic value of lncRNA BANCR in tumor patients: A systematic review and meta-analysis.
    Zhang G; Cai J
    J BUON; 2019; 24(6):2553-2559. PubMed ID: 31983132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of long non-coding RNA five prime to XIST in various cancers.
    Zhou J; Chen J; Chen Z; Wu G; Zhou Z; Wu T; Wang W; Luo Y; Liu T
    BMC Cancer; 2022 Jan; 22(1):61. PubMed ID: 35027040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic and clinicopathological role of long non-coding RNA taurine upregulated 1 in various human malignancies: A systemic review and meta-analysis.
    Wang X; Chen X; Zhang D; Yang G; Yang Z; Yin Z; Zhao S
    Tumour Biol; 2017 Jul; 39(7):1010428317714361. PubMed ID: 28671045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA PANDAR as a prognostic marker in Chinese cancer.
    Ma PJ; Guan QK; Xu DW; Zhao J; Qin N; Jin BZ
    Clin Chim Acta; 2017 Dec; 475():172-177. PubMed ID: 29066211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological and prognostic value of SNHG6 in cancers: a systematic review and a meta-analysis.
    Zhang S; Qiu D; Xie X; Shen Y
    BMC Cancer; 2020 Apr; 20(1):343. PubMed ID: 32321469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic role of long non-coding RNA TUG1 expression in various cancers: a meta-analysis.
    Zhou Y; Lu Y; Li R; Yan N; Li X; Dai T
    Oncotarget; 2017 Nov; 8(59):100499-100507. PubMed ID: 29245996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical prognostic value of lncRNA LINC00675 in cancer patients: A meta-analysis.
    Hua H; Wang J; Zhong P; Mou T; Liu P; Xie F
    Medicine (Baltimore); 2021 Apr; 100(16):e25244. PubMed ID: 33879657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taurine-upregulated gene 1 contributes to cancers through sponging microRNA.
    Zhou H; Gao Z; Wan F
    Acta Biochim Biophys Sin (Shanghai); 2019 Feb; 51(2):123-130. PubMed ID: 30590378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of long non-coding RNA UCA1 in human solid tumors.
    Liu FT; Zhu PQ; Luo HL; Zhang Y; Qiu C
    Oncotarget; 2016 Sep; 7(36):57991-58000. PubMed ID: 27517147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of LncRNA GHET1 predicts an unfavourable survival and clinical parameters of patients in various cancers.
    Jiang YF; Zhang HY; Ke J; Shen H; Ou HB; Liu Y
    J Cell Mol Med; 2019 Aug; 23(8):4891-4899. PubMed ID: 31251476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.